# A Study of LM-24C5 For Advanced Solid Tumors

> **NCT06187402** · PHASE1,PHASE2 · RECRUITING · sponsor: **LaNova Medicines Limited** · enrollment: 49 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** LM-24C5

## Key facts

- **NCT ID:** NCT06187402
- **Lead sponsor:** LaNova Medicines Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-20
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06187402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06187402, "A Study of LM-24C5 For Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06187402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*